UNSPSC 51451806: Albendazole sulfone

This classification denotes an antihelminthic agent with the molecular formula C12H15N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1UIC88380G, chemically known as methyl n-(5-(propane-1-sulfonyl)-1h-1,3-benzodiazol-2-yl)carbamate, but more generally known as albendazole sulfone, which bears US NIH Compound Identifier 53174. European Medicines Agency schedules albendazole sulfone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05295MIG.

Most nations, for tariff purposes, schedule albendazole sulfone under HS 29339990. SMILES: CCCS(=O)(=O)C1CCC2C(C1)NC([NH]2)NC(=O)OC.

UNSPSC 51451806 Albendazole sulfone is a Commodity code that captures pharmaceutical products procured through state and local health agencies, but the recent opportunities posted under this code show minimal alignment with the nominal scope — the two recorded solicitations involve naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems, none of which are albendazole sulfone or related anthelmintic compounds. State and local procurement systems occasionally tag opportunities with broad or mismatched UNSPSC codes, particularly when sourcing through cooperative purchasing consortia or piggyback vehicles where the underlying master contract may span multiple pharmaceutical families. The Illinois Department of Public Health and Seminole County, Florida are the two issuing bodies visible in recent activity, both procuring through competitive bidding processes for essential pharmaceutical supplies and public health support systems rather than parasiticide medications specifically.

The limited recent activity under this code suggests either that albendazole sulfone procurement through state and local channels is sparse, handled through alternative coding, or aggregated within broader pharmaceutical master contracts not visibly itemized at the commodity level. The Illinois award to Chartwell Rx LLC was completed on August 28, 2026 for $2,999,999.11 across a 12-month initial term with renewal options; the Seminole County procurement posted June 30, 2026 with a July 26 response deadline (now closed) for naloxone and drug deactivation systems with quarterly deliveries. Neither opportunity directly reflects demand for albendazole sulfone itself. Business development pursuit of this code should focus on clarifying whether state and local health departments source this active pharmaceutical ingredient through state or national cooperative purchasing agreements, direct wholesale relationships, or consolidated pharmaceutical distribution contracts that may not be individually visible in the UNSPSC-tagged opportunity stream.